Purdue Pharma, Sackler

Sackler, Purdue Pharma $7 Billion Lawsuit: Who's Entitled to Payment
The Office of the Attorney General came to a $7.4 billion settlement with the Sackler family and their company, Purdue Pharma, over their actions leading up to the opioid crisis, which has killed several hundreds of thousands of people in the last two decades.
Sackler family, Purdue Pharma reach $7.4 billion settlement with 15 states over opioid crisis
The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis, New York Attorney General Letitia James announced Thursday.
Purdue and Sackler family agree to $7.4bn national opioid settlement
Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in fuelling the opioid epidemic in the country.
Mass. could get more than $100 million in new OxyContin settlement with Purdue Pharma
The Sackler family and Purdue Pharma agreed to pay $7.4 billion to settle lawsuits over the toll of the powerful prescription painkiller. Massachusetts Attorney General Andrea Campbell said that the state could receive up to $108 million of the settlement money.
Purdue Pharma, Sackler families boost contribution in opioid settlement to $7.4 billion
Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.
Massachusetts to receive more than $100 million from landmark opioid settlement with Purdue Pharma, Sacklers
The deal replaces a previous, $6 billion agreement that was rejected last July by the Supreme Court because it would have protected members of the wealthy Sackler family from civil lawsuits over OxyContin.
Purdue Pharma, Sacklers Settle Opioid Lawsuits For $7.4B
The settlement is the largest deal to date with the people primarily who played an “instrumental role” in driving the opioid crisis, according to the office of Massachusetts Attorney General Andrea Joy Campbell.
Sackler family, Purdue Pharma boost multistate opioid settlement to $7.4B in new agreement
In the latest twist in its efforts to wrap up years of high-profile opioid litigation, the billionaire family behind the now-bankrupt Purdue Pharma, the Sacklers, has come back from last year’s Sup | The billionaire family behind former OxyContin maker Purdue Pharma was denied a bankruptcy protection deal in a high-profile Supreme Court ruling last summer.
Florida to get a share of the new $7.4 billion OxyContin settlement with Purdue Pharma
The deal represents an increase over a previous settlement rejected by the Supreme Court because it protected members of the wealthy Sackler family from civil lawsuits even though they were not in bankruptcy.
Purdue and Sackler family agree $7.4bn opioid settlement
Purdue Pharma and the Sackler family who controlled it have agreed to pay up to $7.4bn (£6bn) to settle claims regarding its powerful prescription painkiller OxyContin. The deal represents an increase of more than $1bn on a previous settlement that was rejected in 2024 by the US Supreme Court, according to news agencies AP and Reuters.
Purdue Pharma to pay TN, other states billions for role in opioid crisis
A bipartisan coalition of states, including Tennessee, will receive $7.4 billion from Purdue Pharma, Inc. and members of the Sackler family for their “instrumental” role in the crisis. The settlement is the largest to date with respect to individuals’ contributions to the opioid crisis.
Settlement with Sackler family may offer Utah vital funds to combat drug overdose epidemic
The agreement, announced Thursday, would require the Sackler family to pay $6.5 billion over the next 15 years and an additional nearly $900 million from Purdue Pharma following its emergence from ...
Purdue Pharma and owners to pay $7.4 billion in settlement of lawsuits over the toll of OxyContin
Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion ...